Japan Production Value by Application and Therapeutic Category: Yearly
Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use
Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data was reported at 16,659,319.000 JPY th in 2024. This records an increase from the previous number of 16,448,843.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data is updated yearly, averaging 10,782,043.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 16,659,319.000 JPY th in 2024 and a record low of 10,782,043.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 16,659,319.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Allergy Drug
Production Value: Require guidance or OTC Drug: Allergy Drug data was reported at 12,852,036.000 JPY th in 2024. This records a decrease from the previous number of 13,079,212.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Allergy Drug data is updated yearly, averaging 8,483,424.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 13,079,212.000 JPY th in 2023 and a record low of 8,483,424.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Allergy Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 12,852,036.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Allergy Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug
Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data was reported at 26,183.000 JPY th in 2024. This records a decrease from the previous number of 38,447.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data is updated yearly, averaging 37,449.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 38,447.000 JPY th in 2023 and a record low of 17,316.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 26,183.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Cardiovascular Preparation
Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data was reported at 13,648,048.000 JPY th in 2024. This records an increase from the previous number of 11,664,231.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data is updated yearly, averaging 8,441,621.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 13,648,048.000 JPY th in 2024 and a record low of 8,283,605.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 13,648,048.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Cardiovascular Preparation from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Cell Activation Drug
Production Value: Require guidance or OTC Drug: Cell Activation Drug data was reported at 1,133,384.000 JPY th in 2024. This records an increase from the previous number of 958,703.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Cell Activation Drug data is updated yearly, averaging 1,239,409.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 1,239,409.000 JPY th in 2021 and a record low of 958,703.000 JPY th in 2023. Production Value: Require guidance or OTC Drug: Cell Activation Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,133,384.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Cell Activation Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Central Nervous System Agent
Production Value: Require guidance or OTC Drug: Central Nervous System Agent data was reported at 161,516,128.000 JPY th in 2024. This records an increase from the previous number of 153,744,144.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data is updated yearly, averaging 115,937,480.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 161,516,128.000 JPY th in 2024 and a record low of 115,937,480.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 161,516,128.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Central Nervous System Agent from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Chemotherapeutics
Production Value: Require guidance or OTC Drug: Chemotherapeutics data was reported at 526,480.000 JPY th in 2024. This records a decrease from the previous number of 844,979.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Chemotherapeutics data is updated yearly, averaging 335,594.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 844,979.000 JPY th in 2023 and a record low of 307,086.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Chemotherapeutics data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 526,480.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Chemotherapeutics from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Crude Drug
Production Value: Require guidance or OTC Drug: Crude Drug data was reported at 1,047,689.000 JPY th in 2024. This records a decrease from the previous number of 1,131,888.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Crude Drug data is updated yearly, averaging 1,998,156.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 3,432,367.000 JPY th in 2019 and a record low of 1,047,689.000 JPY th in 2024. Production Value: Require guidance or OTC Drug: Crude Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,047,689.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Crude Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Dermatological Drug
Production Value: Require guidance or OTC Drug: Dermatological Drug data was reported at 199,562,371.000 JPY th in 2024. This records an increase from the previous number of 189,833,352.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Dermatological Drug data is updated yearly, averaging 185,637,006.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 199,562,371.000 JPY th in 2024 and a record low of 170,530,645.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Dermatological Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 199,562,371.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Dermatological Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Digestive Organ Agent
Production Value: Require guidance or OTC Drug: Digestive Organ Agent data was reported at 78,990,960.000 JPY th in 2024. This records a decrease from the previous number of 79,017,161.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data is updated yearly, averaging 69,857,276.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 79,148,279.000 JPY th in 2019 and a record low of 69,580,520.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 78,990,960.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Digestive Organ Agent from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Dispensing Drug
Production Value: Require guidance or OTC Drug: Dispensing Drug data was reported at 1,605,149.000 JPY th in 2024. This records an increase from the previous number of 1,525,023.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Dispensing Drug data is updated yearly, averaging 1,951,166.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 2,657,033.000 JPY th in 2020 and a record low of 1,525,023.000 JPY th in 2023. Production Value: Require guidance or OTC Drug: Dispensing Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,605,149.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Dispensing Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription
Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data was reported at 8,906,836.000 JPY th in 2024. This records a decrease from the previous number of 9,755,293.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data is updated yearly, averaging 9,431,529.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 10,047,896.000 JPY th in 2022 and a record low of 8,906,836.000 JPY th in 2024. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 8,906,836.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic
Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data was reported at 15,152,553.000 JPY th in 2024. This records an increase from the previous number of 5,644,555.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data is updated yearly, averaging 3,347,943.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 15,152,553.000 JPY th in 2024 and a record low of 3,102,529.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 15,152,553.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Hormones, include Antihormones
Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data was reported at 173,398.000 JPY th in 2024. This records an increase from the previous number of 137,878.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data is updated yearly, averaging 126,903.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 538,684.000 JPY th in 2020 and a record low of 126,903.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 173,398.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Hormones, include Antihormones from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Nourishing Tonic
Production Value: Require guidance or OTC Drug: Nourishing Tonic data was reported at 42,386,644.000 JPY th in 2024. This records a decrease from the previous number of 45,522,310.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Nourishing Tonic data is updated yearly, averaging 43,303,470.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 47,285,657.000 JPY th in 2020 and a record low of 42,386,644.000 JPY th in 2024. Production Value: Require guidance or OTC Drug: Nourishing Tonic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 42,386,644.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Nourishing Tonic from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ
Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data was reported at 3,532.000 JPY th in 2022. This records a decrease from the previous number of 7,064.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data is updated yearly, averaging 5,200.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 7,064.000 JPY th in 2021 and a record low of 3,337.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 3,532.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Other Metabolic Drug
Production Value: Require guidance or OTC Drug: Other Metabolic Drug data was reported at 45,005,080.000 JPY th in 2024. This records an increase from the previous number of 40,125,067.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data is updated yearly, averaging 35,332,500.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 45,005,080.000 JPY th in 2024 and a record low of 35,332,500.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 45,005,080.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Other Metabolic Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose
Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data was reported at 1,815,962.000 JPY th in 2024. This records a decrease from the previous number of 2,295,917.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data is updated yearly, averaging 3,751,882.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 3,751,882.000 JPY th in 2021 and a record low of 1,815,962.000 JPY th in 2024. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,815,962.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug
Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data was reported at 56,672.000 JPY th in 2024. This records a decrease from the previous number of 93,959.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data is updated yearly, averaging 70,527.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 93,959.000 JPY th in 2023 and a record low of 52,301.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 56,672.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent
Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data was reported at 3,950,825.000 JPY th in 2024. This records an increase from the previous number of 2,542,442.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data is updated yearly, averaging 1,785,444.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 4,632,208.000 JPY th in 2022 and a record low of 645,305.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 3,950,825.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Public Health Drug
Production Value: Require guidance or OTC Drug: Public Health Drug data was reported at 14,188,770.000 JPY th in 2024. This records a decrease from the previous number of 17,255,782.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Public Health Drug data is updated yearly, averaging 17,963,439.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 19,253,424.000 JPY th in 2019 and a record low of 14,188,770.000 JPY th in 2024. Production Value: Require guidance or OTC Drug: Public Health Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 14,188,770.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Public Health Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Respiratory Organ Agent
Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data was reported at 37,907,006.000 JPY th in 2024. This records an increase from the previous number of 32,754,582.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data is updated yearly, averaging 19,496,666.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 37,907,006.000 JPY th in 2024 and a record low of 19,496,666.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 37,907,006.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Respiratory Organ Agent from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Sensory Organ Agent
Production Value: Require guidance or OTC Drug: Sensory Organ Agent data was reported at 100,794,901.000 JPY th in 2024. This records an increase from the previous number of 100,144,678.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data is updated yearly, averaging 85,197,887.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 100,794,901.000 JPY th in 2024 and a record low of 85,197,887.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 100,794,901.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Sensory Organ Agent from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines
Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data was reported at 56,934,384.000 JPY th in 2024. This records an increase from the previous number of 54,873,065.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data is updated yearly, averaging 40,457,972.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 56,934,384.000 JPY th in 2024 and a record low of 38,289,946.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 56,934,384.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug
Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data was reported at 9,396,218.000 JPY th in 2024. This records a decrease from the previous number of 9,627,827.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data is updated yearly, averaging 8,952,964.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 9,627,827.000 JPY th in 2023 and a record low of 7,699,150.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 9,396,218.000 2024 | yearly | 2019 - 2024 |
View Japan's Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug from 2019 to 2024 in the chart:
Production Value: Require guidance or OTC Drug: Vitamins
Production Value: Require guidance or OTC Drug: Vitamins data was reported at 108,829,277.000 JPY th in 2024. This records an increase from the previous number of 91,253,492.000 JPY th for 2023. Production Value: Require guidance or OTC Drug: Vitamins data is updated yearly, averaging 75,251,979.000 JPY th from Dec 2019 (Median) to 2024, with 6 observations. The data reached an all-time high of 108,829,277.000 JPY th in 2024 and a record low of 69,515,229.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Vitamins data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 108,829,277.000 2024 | yearly | 2019 - 2024 |